Competition – Abuse of dominant position. The Competition Appeal Tribunal dismissed the application by Flynn Pharma Ltd and its associated company (Flynn) for interim relief pursuant to r 24 of the Competition Appeal Tribunal Rules 2015, SI 2015/1648, in the form of a request for the suspension of directions given in a decision made against it by the Competition and Markets Authority. The tribunal held that, having considered all the relevant factors, the balance of interests lay against not granting Flynn interim relief.